YouTube Twitter Facebook

+44 (0)1491 845360 info-ous@toraxmedical.com

LINX Clinical Data

Please click on the links included below to learn more about the results of studies conducted on the LINX® Reflux Management System.

Title Abstract Link
Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients The efficacy and safety of magnetic sphincter augmentation (MSA) with the LINX device (Torax Medical) has been reported in several short-and long-term studies, rivaling historic results of laparoscopic Nissen fundoplication (LNF), but with fewer side effects. However, there have been no studies comparing patients with similar disease to validate these results. View
One Hundred Consecutive Patients Treated with Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease: 6 Years of Clinical Experience from a Single Center. This study was undertaken to evaluate our clinical experience during a 6-year period with an implantable device that augments the lower esophageal sphincter for gastroesophageal reflux disease (GERD). View
Oesophageal Sphincter Device for Gastroesophageal Reflux Disease Patients with gastroesophageal reflux disease who have a partial response to proton-pump inhibitors often seek alternative therapy. We evaluated the safety and effectiveness of a new magnetic device to augment the lower esophageal sphincter View
Laparoscopic Sphincter Augmentation Device Eliminates Reflux Symptoms and Normalizes Oesophageal Acid Exposure. One- and 2-year evaluation of a feasibility trial (clinicaltrials.gov registration numbers NCT01057992, NCT01058070, and 01058564) to assess the safety and efficacy of a laparoscopically implanted sphincter augmentation device for the treatment of gastroesophageal reflux disease (GERD). View
Magnetic Augmentation of the Lower Oesophageal Sphincter: Results of a Feasibility Clinical Trial. The high prevalence of gastroesophageal reflux disease continues to encourage the development of treatment modalities to fill the gap between acid-suppression therapy and the laparoscopic Nissen fundoplication. View
Use of a Magnetic Sphincter for the Treatment of GORD: A Feasibility Study. The success of fundoplication surgery varies widely; furthermore, complications after fundoplication can be common. We introduced a new device to treat GERD: biomechanical augmentation of the lower esophageal sphincter (LES) by use of a magnetic reinforcing appliance. View
Magnetic Sphincter Augmentation and Fundoplication for GERD in Clinical Practice: One-year Results of a Multicenter, Prospective Observational Study The techniques available for antireflux surgery have expanded with the introduction of the magnetic sphincter augmentation device (MSAD) for gastroesophageal reflux disease (GERD). View
Long-Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux  Based on results from year 2 of a 5-year trial, in 2012 the US Food and Drug Administration approved the use of a magnetic device to augment lower esophageal sphincter function in patients with gastroesophageal reflux disease (GERD). We report the final results of 5 years of follow-up evaluation of patients who received this device. View
Multi-institutional Outcomes using Magnetic Sphincter Augmentation versus Nissen Fundoplication for Chronic Gastroesophageal Reflux Disease  Magnetic sphincter augmentation (MSA) has emerged as an alternative surgical treatment of gastroesophageal reflux disease (GERD). The safety and efficacy of MSA has been previously demonstrated, although adequate comparison to Nissen fundoplication (NF) is lacking, and required to validate the role of MSA in GERD management. View
Efficacy of Magnetic Sphincter Augmentation in Patients with Large Hiatal Hernias Magnetic sphincter augmentation (MSA) has demonstrated long-term safety and efficacy in the treatment of patients with gastroesophageal reflux disease (GERD), but its efficacy in patients with large hiatal hernias has yet to be proven. The aim of this study was to assess outcomes of MSA in patients with hiatal hernias ≥ 3 cm. View
Torax Medical are proud to support the charity FORT - Fighting Oesophageal Reflux Together